Bupropion Hydrochloride 16571-0863-03
- Manufacturer
- Rising Pharma Holdings, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 1, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA211020
Need to source Bupropion Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bupropion Hydrochloride | 300 mg/1 |
Drug Class
Aminoketone [EPC]Dopamine Uptake Inhibitors [MoA]Increased Dopamine Activity [PE]
Selected Package
16571-0863-03Selected30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-03)
Other packages for this product(3)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-09)
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-10)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-50)